phenylmethylsulfonyl fluoride has been researched along with valproic acid in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Cioczek-Czuczwar, A; Czuczwar, P; Czuczwar, SJ; Luszczki, JJ | 1 |
| Andres-Mach, M; Chmielewski, J; Florek-Luszczki, M; Kondrat-Wrobel, MW; Luszczki, JJ; Patrzylas, P; Szpringer, M; Zagaja, M; Zaluska, K | 1 |
| Andres-Mach, M; Haratym-Maj, A; Maj, M; Rola, R; Szewczyk, A; Zagaja, M; Łuszczki, JJ | 1 |
4 other study(ies) available for phenylmethylsulfonyl fluoride and valproic acid
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Arachidonyl-2'-chloroethylamide, a highly selective cannabinoid CB1 receptor agonist, enhances the anticonvulsant action of valproate in the mouse maximal electroshock-induced seizure model.
Topics: Amidohydrolases; Animals; Anticonvulsants; Arachidonic Acids; Avoidance Learning; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Electroshock; Enzyme Inhibitors; Forelimb; Male; Memory; Mice; Molecular Structure; Muscles; Phenylmethylsulfonyl Fluoride; Receptor, Cannabinoid, CB1; Seizures; Time Factors; Valproic Acid | 2006 |
Effects of arachidonyl-2'-chloroethylamide (ACEA) on the protective action of various antiepileptic drugs in the 6-Hz corneal stimulation model in mice.
Topics: Acetamides; Animals; Anticonvulsants; Arachidonic Acids; Avoidance Learning; Benzodiazepines; Clobazam; Cornea; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Electroshock; Epilepsy, Complex Partial; Lacosamide; Levetiracetam; Male; Mice; Muscle Strength; Nipecotic Acids; Phenobarbital; Phenylmethylsulfonyl Fluoride; Piracetam; Psychomotor Performance; Receptor, Cannabinoid, CB1; Tiagabine; Valproic Acid | 2017 |
Levetiracetam combined with ACEA, highly selective cannabinoid CB1 receptor agonist changes neurogenesis in mouse brain.
Topics: Animals; Anticonvulsants; Astrocytes; Avoidance Learning; Brain; Disease Models, Animal; Electroshock; Levetiracetam; Male; Mice, Inbred C57BL; Neural Stem Cells; Neurogenesis; Phenylmethylsulfonyl Fluoride; Receptor, Cannabinoid, CB1; Valproic Acid | 2019 |